RossStuartBerkowitzMD
Obstetrics & Gynecology • Boston, MAGynecologic Oncology
Gyn Oncology at Brigham and Women's Hospital
Dr. Berkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-8843
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1978 - 1980- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1975 - 1978
- Brigham and Women's HospitalResidency, Surgery, 1973 - 1975
Boston University School of MedicineClass of 1973
Certifications & Licensure
NH State Medical License 2022 - 2026
RI State Medical License 2021 - 2026
VT State Medical License 2022 - 2026
CT State Medical License 2022 - 2025
MA State Medical License 1978 - 2025
ME State Medical License 2022 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
- Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod Start of enrollment: 2008 Aug 01
- Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer Start of enrollment: 2008 Sep 01
Publications & Presentations
PubMed
- 56 citationsAnalysis of p73 in human borderline and invasive ovarian tumor.Shu Wing Ng, Gary K. Yiu, Yan Liu, Lee Wen Huang, Madhuri Palnati
Oncogene. 2000-04-06 - 1365 citationsCell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M. Wolf, Alexander J. Lazar
Cell. 2018-04-05 - 209 citationsHaptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometryBin Ye, Daniel W. Cramer, Steven J. Skates, Steven P. Gygi, Vanessa Pratomo
Clinical Cancer Research. 2003-08-01
Journal Articles
- Distinct microRNA Profiles for Complete Hydatidiform Moles at Risk for Malignant ProgressionNeil S Horowitz, Donald P Goldstein, Bradley J Quade, Ross S Berkowitz, Kevin M Elias, American Journal of Obstetrics and Gynecology
- Update on the Diagnosis and Management of Gestational Trophoblastic DiseaseRoss S Berkowitz, John R Lurain, International Journal of Gynecology & Obstetrics
- Comparison of Benign Peritoneal Fluid- and Ovarian Cancer Ascites-Derived Extracellular Vesicle RNA BiomarkersRoss S Berkowitz, Michael G Muto, BioMed Central
Press Mentions
Your Daily Phil: Moishe House Opens 30 New Locations + Connecting Shmita to FundraisingOctober 4th, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
